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700Prosthetic graft infections involving the femoral
artery
Jeffrey J. Siracuse, MD, Prathima Nandivada, MD, Kristina A. Giles, MD, Allen D. Hamdan, MD,
Mark C. Wyers, MD, Elliot L. Chaikof, MD, PhD, Frank B. Pomposelli, MD, and
Marc L. Schermerhorn, MD, Boston, Mass
Background: Prosthetic graft infection is a major complication of peripheral vascular surgery. We investigated the expe-
rience of a single institution over 10 years with bypass grafts involving the femoral artery to determine the incidence and
risk factors for prosthetic graft infection.
Methods: A retrospective cohort single-institution review of prosthetic bypass grafts involving the femoral artery from
2001 to 2010 evaluated patient demographics, body mass index, comorbidities, indications, location of bypass, type of
prosthetic material, case urgency, and previous ipsilateral bypass or percutaneous interventions and evaluated the inci-
dence of graft infections, amputations, and mortality.
Results: There were 496 prosthetic grafts identiﬁed with a graft infection rate of 3.8% (n [ 19) at a mean follow-up of
27 months. Multivariable analysis showed that redo bypass (hazard ratio [HR], 5.8; 95% conﬁdence interval [CI],
2.2-15.0), active infection at the time of bypass (HR, 5.2; 95% CI, 1.9-14.2), female gender (HR, 4.5; 95% CI, 1.6-12.7),
and diabetes mellitus (HR, 4.6; 95% CI, 1.5-14.3) were signiﬁcant predictors of graft infection. Graft infection was
predictive of major lower extremity amputation (HR, 9.8; 95% CI, 3.5-27.1), as was preoperative tissue loss (HR, 4.7;
95% CI, 1.8-11.9). Graft infection did not predict long-term mortality; however, chronic renal insufﬁciency (HR, 2.3;
95% CI, 1.6-3.4), tissue loss (HR, 1.4; 95% CI, 1.0-1.9), and active infection (HR, 2.3; 95% CI, 1.6-3.4) did. Infected
grafts were removed 79% of the time. Staphylococcus epidermidis (37%) and methicillin-sensitive Staphylococcus aureus
(26%) were the most common pathogens isolated.
Conclusions: Redo bypass, female gender, diabetes, and active infection at the time of bypass are associated with a higher
risk for prosthetic graft infection and major extremity amputation but do not confer an increased risk of mortality.
Autologous vein for lower extremity bypass and endovascular interventions should be considered when feasible in
high-risk patients (J Vasc Surg 2013;57:700-5.)Surgical site infections (SSIs) after lower extremity
bypass are common and potentially serious complications
that can be associated with a high morbidity rate.1 Predic-
tors of SSI after surgical bypass include obesity, diabetes,
poor preoperative functional status, a history of smoking,
and female gender.2,3 These SSIs occasionally lead to graft
infection with rates of postoperative amputation and
mortality of 52% and 58% having been reported.4 These
prosthetic graft infections are not infrequent with a re-
ported incidence of 4.7%.5 Aside from the adverse effect
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often require additional procedures and a lengthier inpa-
tient stay.6 Reported treatments include removal of the
graft and graft preservation with the use of vacuum-
assisted closure (VAC) devices, with or without muscle
ﬂap coverage.4,7-9 More recently, the trend has been to
move away from graft removal with the latter options
more commonly employed.7-9
Several previous studies have looked at infectious
complications after bypass involving the femoral artery.
However, there are few studies that distinguish wound
infections from infections involving the graft. Prior larger
studies that speciﬁcally looked at infected prosthetic grafts
were conducted before the identiﬁcation of methicillin-
resistant Staphylococcus aureus (MRSA), did not stratify
by wound location or operative indication and did not
perform statistical analysis to determine risk factors.4,10,11
Other previous analyses had a small sample size and
included vein grafts in their analysis with only a small
proportion of the cases involving prosthetic grafts.5,12,13
Beth Israel Deaconess Medical Center is a large referral
center and university hospital with a high volume of
patients with lower extremity vascular disease. We exam-
ined our 10-year experience with infected prosthetic grafts
after surgical bypass involving the femoral artery to identify
predictive risk factors. We also examined the impact of
postoperative graft infection on amputation rates and
mortality.
Fig 1. Graft infection rate was 3.8% with a median time to
presentation of 98 days postoperatively.
JOURNAL OF VASCULAR SURGERY
Volume 57, Number 3 Siracuse et al 701METHODS
We performed a retrospective cohort study of all
patients undergoing prosthetic bypass grafts involving the
femoral artery from 2001 to 2010 performed by the Divi-
sion of Vascular and Endovascular Surgery at Beth Israel
Deaconess Medical Center. We deﬁned a graft infection
as the presence of purulent ﬂuid directly communicating
with the graft or an exposed graft. Patient demographics,
body mass index, comorbidities, indications for interven-
tion, location of bypass, type of prosthetic material, case
urgency, and previous ipsilateral bypass or percutaneous
interventions were recorded. The primary end point was
graft infection; postoperative amputation and mortality
were analyzed as secondary end points. The selection of
the bypass conduit depends on the surgeon; however,
generally, we preferentially use great saphenous vein, fol-
lowed by prosthetic graft for claudicants and great saphe-
nous vein followed by either arm vein or short saphenous
vein before prosthetic graft in cases of limb threat.
Follow-up is variable, but patients generally are seen three
to four times per year for 2 years and then one to two times
per year thereafter. Long-term survival was checked with
the Social Security Death Index. An active infection at
the time of bypass was deﬁned as an infection in the limb
in which bypass was performed or bypass performed for
management of an infected graft at another site, such as
an axillary-femoral bypass performed for an infected aortic
graft.
We use longitudinal incisions in the groin, which we
then closed with two layers of running polyglactin 910
(Vicryl) sutures followed by skin closure with staples. Use
of antimicrobial incise drape (Ioban; 3M, St. Paul, Minn)
was surgeon-speciﬁc with most surgeons not using Ioban,
and no VAC devices were used prophylactically. Our
protocol is to administer antibiotics 60 minutes before
skin incision. Our regimen has evolved over time during
this study period from cefazolin alone to vancomycin and
gentamicin in 2005 and to vancomycin and cefazolin in
2010 per hospital policy. These protocols did change
over time in consultation with our infectious disease divi-
sion based on institutional culture data. Povidone-iodine
(Betadine) was used for preparation unless there was
a contraindication throughout the study period. After this
study period, we switched to chlorhexidine gluconate
with isopropyl alcohol (Hibiclens) as our standard prepara-
tion solution per hospital policy. Routine Hibiclens use
preoperatively was started after the study period. For the
ﬁrst 6 years, we used razors and then switched to electrical
clips thereafter. In the middle of the study period, our divi-
sion developed and evolved its endovascular surgery
program, giving us more options to treat patients.1
Categorical variables were analyzed by Pearson c2 and
the Fisher exact test. Treatment outcomes during the
course of follow-up were analyzed using Kaplan-Meier
methodology, and time-to-failure curves were compared
with the log-rank test and Cox proportional hazards.
Univariate and multivariable Cox regression models wereused to assess predictor variables for time-dependent
outcomes. Statistical signiﬁcance was deﬁned as P < .05.
All statistical tests were done using STATA 8 software
(StataCorp, College Station, Tex).
RESULTS
There were 496 prosthetic grafts involving the femoral
artery in 478 patients from 2001 to 2010 performed at our
institution. The average patient age was 69 years, and 58%
of the patients were men. Mean follow-up was 27 months.
The graft infection rate was 3.8% (19/496) with the median
time to presentation after bypass of 98 days (Fig 1). Graft
infections were more common in women than men (6.8%
vs 1.7%; P < .01), patients with diabetes mellitus vs no dia-
betes mellitus (6.5% vs 1.9%; P < .01), patients with limb
threat vs claudication (5.2% vs 2.6%; P < .05), patients with
active infection at the time of bypass (11.7% vs 2.9%; P <
.01), patients with redo bypass (11.5% vs 2.0%; P < .01),
and patients with chronic renal insufﬁciency (6.4% vs 3.3%;
P ¼ .05) (Tables I-III). By multivariable analysis, female
gender (hazard ratio [HR], 4.5; 95% conﬁdence interval
[CI], 1.6-12.7), diabetes mellitus (HR, 4.6; 95% CI,
1.5-14.3), redo bypass (HR, 5.8; 95% CI, 2.2-15.0), and
active infection (HR, 2.3; 95% CI, 1.6-3.4) were indepen-
dent predictors of prosthetic graft infection (Table IV).
The location of the bypass was not predictive of graft
infection (Table II). The type of prosthetic material also
did not predict graft infection because there was no differ-
ence between polyethylene terephthalate (Dacron) (3%)
and polytetraﬂuoroethylene (4.3%) grafts. Previous minor
ipsilateral amputation and previous percutaneous access of
the ipsilateral femoral artery were not predictive of graft
infection. A second bypass performed at the initial opera-
tion and concurrent stenting were also not predictive.
Grafts were occluded 11% of the time in infected grafts
and 13% of the time in noninfected grafts (not signiﬁcant).
Limbs underwent reintervention on postbypass 14% of the
time in noninfected grafts and 11% of the time in infected
Table I. Patient characteristics
Total
(percentage of total with characteristic)
Graft infection rate
with characteristic
Graft infection rate
without characteristic P
Patients 496 3.8% — —
Obese (BMI >30) 90 (18%) 3.7% 3.9% .7
Female gender 206 (42%) 6.8% 1.7% <.01
Emergent 48 (10%) 4.2% 3.8% .6
Coronary artery disease 187 (38%) 3.7% 3.8% .7
Diabetes mellitus 230 (46%) 6.5% 1.9% <.01
Hypertension 368 (74%) 3.8% 3.9% .7
Chronic renal insufﬁciency 78 (16%) 6.4% 3.3% .05
Former smoker 180 (36%) 3.8% 3.8% .9
Current smoker 186 (38%) 2.7% 4.5% .4
BMI, Body mass index.
Table II. Procedures
Bypass type
Total
(percentage undergoing procedure)
Graft infection rate
with procedure
Graft infection rate
with other procedures P
Femoral-femoral 102 (21%) 4.2% 3.6% .6
Iliofemoral 17 (3.4%) 5.2% 3.8% .5
Femoral-popliteal 185 (37%) 3.2% 3.9% .9
Femoral-distal 51 (10%) 5.9% 3.6% .4
Axillary-femoral 73 (15%) 4.1% 3.8% .7
Aorta-femoral 84 (17%) 1.2% 4.4% .3
Table III. Limb history
Characteristics
Total
(percentage with characteristic)
Graft infection rate
with characteristic
Graft infection rate
without characteristic P
Limb threat 267 (53%) 5.2% 2.9% <.05
Tissue loss 142 (29%) 4.2% 3.7% .7
Active infection 51 (10%) 11.7% 2.9% <.01
Prior percutaneous access 295 (60%) 4.4% 3.0% .7
Redo bypass 96 (19%) 11 (11.5%) 2.0% <.01
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otic administration and incision was 24 minutes. The rate
of infection in patients who received antibiotics >1 hour
was 11.1% (not signiﬁcant); however, this represents only
one patient. The average operating time was 167 minutes,
and case length was not associated with graft infection.
Suture lines were involved 79% of the time. Staphylo-
coccus epidermidis was the most common isolate present in
cultures from 37% of infected grafts manifesting at a median
of 163 days postoperatively followed bymethicillin-sensitive
Staphylococcus aureus cultured in 26%. Surprisingly, MRSA
was cultured in only 5% of graft infections (Table V). Graft
infections with no growth had graft exposed.
All amputations after graft infection occurred during the
readmission for the graft infection, and allwerewithin30days
of diagnosis of graft infection. The median length of stay
for readmission for graft infection was 11 days (range,8-94 days). There were no additional complications in 53%
of the patients with graft infections. Excluding major ampu-
tations, other complications included one patient with dia-
betic ketoacidosis, two patients with minor amputations,
and one patient with acute myocardial infarction who ulti-
mately died. One patient, who had an above-knee amputa-
tion, had recurrent infections requiring further
debridement. Of the 19 patients who were discharged, 11
went home with services, and the others went to rehabilita-
tion facilities. All patients without amputations were fully
ambulatory at the time of discharge. Of all infected grafts,
74% (14/19) were removed; however, in the last 3 years of
this study period, only 50% (3/6) of the infected grafts
were removed. Preservation of the grafts in these cases used
a sartorius muscle ﬂap in one case, and all cases had VAC
devices placed.All preservedgraftswere successfully salvaged,
and none of the patients went on to amputation. Vascular
Table IV. Multivariable predictors of graft infections
HR 95% CI
Redo bypass 5.8 2.2-15.0
Active infection 5.2 1.9-14.2
Diabetes mellitus 4.6 1.5-14.3
Female gender 4.5 1.6-12.7
CI, Conﬁdence interval; HR, heart rate.
Table V. Bacteria isolated
%
Staphylococcus epidermidis 37
Methicillin-sensitive Staphylococcus aureus 26
Enterococcus 10
Methicillin-resistant S. aureus 5
Pseudomonas aeruginosa 5
Streptococcus pyogenes 5
Klebsiella pneumoniae 5
Corynebacterium 5
Polymicrobial 10
No growth 10
Fig 2. Graft infection predicts major amputation of the affected
limb.
Fig 3. There is no signiﬁcant difference in long-term survival
between patients with infected grafts and patients without infected
grafts.
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the patients who had grafts removed, none of whomwent on
to have a major amputation. The remaining limbs were not
reconstructed because they were not salvageable secondary
to the extent of infection and lack of conduit. Five of seven
patients (71%) without vascular reconstruction who had
grafts removed went on to major lower extremity
amputation.
Graft infection was predictive of major lower extremity
amputation (HR, 9.8; 95% CI, 3.5-27.1). Freedom from
amputation was 94% in patients without graft infection
and 71% in patients with graft infections at 1 year (Fig 2).
Preoperative tissue loss in the ipsilateral limb was also
predictive of amputation (HR, 4.7; 95% CI, 1.8-11.9).
Graft infection did not predict an increase in long-term
mortality (Fig 3). However, chronic renal insufﬁciency
(HR, 2.3; 95% CI, 1.6-3.4), tissue loss (HR, 1.4; 95% CI,
1.0-1.9), and active infection (HR, 2.3; 95% CI, 1.6-3.4)
were predictive of overall late mortality.
DISCUSSION
The infection rate of prosthetic grafts involving the
groin in our series was 3.8% at a mean follow-up of 27
months. There was no difference in the incidence in graft
infection over the 10-year study period. Predictors of graft
infection were redo bypass, active infection at the time of
bypass, female gender, and diabetes mellitus. Graft infec-
tion was predictive of major lower extremity amputation,
as was preoperative tissue loss. However, graft infection
did not predict mortality. Over time, we have been increas-
ingly managing graft infections without graft removal.
Our graft infection rate is similar to previously pub-
lished rates ranging from 4.3% to 4.7%.5,10 Chang et al5looked at predictors of graft infections, most of which
were vein grafts, and found that only operative time was
predictive of graft infections after lower extremity bypass.
No other studies looked at predictors of graft infections.
The association of female genderwith SSI andwith pros-
thetic graft infection as noted in our series may be due to
a higher fat distribution in the lower extremities, inconti-
nence causing wound contamination, or other factors.14,15
We also found diabetes to be predictive of graft infection,
which is not surprising because it is also associated with
SSIs not only in the lower extremities but also in other
surgical procedures.16 Although perioperative tight glucose
control in diabetics is protective against cardiovascular
complications, it has not been shown to decrease wound
complications, most likely owing to the deleterious effects
of diabetes aside from hyperglycemia.17,18
The presence of an active infection at the time of the
operation was also predictive of prosthetic graft infection,
most likely owing to contamination during the procedure
or perioperative period. Active infection has previously
been shown to be a risk for SSIs.2 A redo operation was
JOURNAL OF VASCULAR SURGERY
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ring and poor vascular supply to the surgical bed; this
was not previously shown to be a predictive factor for
surgical site or graft infections.2,3,5 Body mass index was
not predictive of graft infection, which is surprising because
it is closely linked to SSI after lower extremity bypass.2 We
also did not ﬁnd an association with smoking or length of
operation. However, the lack of associations in our series
may have been due to a type II error owing to the small
number of infected grafts.
Graft infection was predictive of amputation because
some patients who required graft removal had no recon-
structive options or the limbs were not salvageable at the
time of presentation with graft infection. Mertens et al11
showed that infrainguinal prosthetic graft infection had a 40%
amputation risk at 1 year. However, prior studies looking at
graft infections have not analyzed if graft infection is an inde-
pendent predicator of major lower extremity amputa-
tion.4,5,10,11 Use of cryopreserved veins has been reported
with some success as an alternative conduit option to avoid
amputation.19 We did not use this option in this study period;
however,wehave subsequentlyused itwith short-termsuccess.
Our management for these graft infections has changed
over time. In theﬁrst 7 years of our study, all grafts except one
were removed. However, in the latter 3 years, 50% were
preserved by debridement with placement of a VAC device,
with or without local rotational muscle ﬂap closure. This
practice parallels the national trend, which has shown success
with graft preservation by using sartorius or gracilis muscle
ﬂaps with and without VAC devices.7-9,19 Our grafts that
had a sartorius muscle ﬂap and a VAC device alone were
successfully salvaged as has been previously shown with
both vein and prosthetic grafts with complete success with
sartoriusﬂaps andgreater than90% successwithVACdevices
alone with two failures from bleeding at the anastomosis and
a recurrent infection previously reported.8,9 In the past 2
decades, the incidence of MRSA has greatly increased, and
it has become an important pathogen in vascular SSIs,
contributing to 33% of SSIs in patients undergoing vascular
surgery.20-22 Surprisingly, MRSA was seen in only 5% of
our graft infections, with S. epidermidis, methicillin-sensitive
S. aureus, and Enterococcus being more prevalent.
There are several limitations to our study. It is a single-
center retrospective review. There was no standardization for
the choice of conduit; rather, it was surgeon dependent and
based on personal preference, which could cause selection
bias because patients who are viewed as high risk may have
more vein options exhausted before using a prosthetic.
However, this study is the largest statistical analysis ofprosthetic
grafts involving the femoral artery and is the only study to
look at predictors of infections exclusively in prosthetic grafts.
CONCLUSIONS
Prosthetic graft infections were seen in 3.8% of bypass
grafts involving the femoral artery. Redo bypass, female
gender, diabetes, and active infection at the time of
bypass are associated with a higher risk for graft infection,
which results in subsequent early major extremity am-putation but does not confer an increased risk of mortality.
Alternative sources of vein and endovascular interventions
should be considered preferentially in these high-risk pa-
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